Shefali Agarwal is of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 286,539 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Shefali Agarwal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
286,539 Reduced 100.0%
0 Common Stock, par valu...
Aug 09 2022
SELL
Payment of exercise price or tax liability
$518,684 $1.39 p/Share
373,154 Reduced 56.65%
285,562 Common Stock, par valu...
Aug 09 2022
BUY
Exercise of conversion of derivative security
$695,000 $1.39 p/Share
500,000 Added 43.15%
658,716 Common Stock, par valu...
Feb 28 2022
BUY
Grant, award, or other acquisition
$2,960 $1.27 p/Share
2,331 Added 1.45%
158,716 Common Stock
Feb 07 2022
SELL
Open market or private sale
$1,587 $1.5 p/Share
1,058 Reduced 0.67%
156,385 Common Stock, par valu...
Feb 02 2022
SELL
Open market or private sale
$3,615 $1.37 p/Share
2,639 Reduced 1.65%
157,443 Common Stock, par valu...
Jan 26 2022
SELL
Open market or private sale
$5,902 $2.02 p/Share
2,922 Reduced 1.79%
160,082 Common Stock, par valu...
Dec 06 2021
SELL
Open market or private sale
$5,215 $2.93 p/Share
1,780 Reduced 1.08%
163,004 Common Stock, par valu...
Aug 16 2021
BUY
Grant, award, or other acquisition
-
59,166 Added 26.57%
163,507 Common Stock, par valu...
Feb 04 2021
SELL
Open market or private sale
$10,862 $11.21 p/Share
969 Reduced 0.92%
104,341 Common Stock, par valu...
Feb 01 2021
BUY
Grant, award, or other acquisition
-
29,583 Added 21.93%
105,310 Common Stock
Jan 25 2021
SELL
Open market or private sale
$32,770 $11.41 p/Share
2,872 Reduced 3.65%
75,727 Common Stock, par valu...
Dec 03 2020
SELL
Open market or private sale
$34,148 $13.54 p/Share
2,522 Reduced 3.21%
76,089 Common Stock, par valu...

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
GRTS
Gritstone bio, Inc. Healthcare
SA

Shefali Agarwal

Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Track Activities on EPZM